Aclaris Therapeutics annual gross margin
2017
2018
Aclaris Therapeutics Gross Margin Growth & History (ACRS)
Aclaris Therapeutics's gross margin was 52.69% for fiscal 2018.
View full Aclaris Therapeutics company overviewAclaris Therapeutics annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2018 | 2018-12-31 | 52.69% | +24.41 pp |
| 2017 | 2017-12-31 | 28.28% | — |
Aclaris Therapeutics quarterly gross margin
Q3.17
Q1.18
Q2.18
Q3.18
Q4.18
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q4 2018 | 2018-12-31 | 66.95% | +33.17 pp |
| Q3 2018 | 2018-09-30 | 38.91% | — |
| Q2 2018 | 2018-06-30 | 67.87% | — |
| Q1 2018 | 2018-03-31 | 13.51% | — |
| Q3 2017 | 2017-09-30 | 33.77% | — |
Aclaris Therapeutics gross margin trends
Across the available reported history, Aclaris Therapeutics's gross margin increased from 28.28% to 52.69%, a change of +24.41 percentage points. The latest reported quarter, Q4 2018, shows 66.95%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Aclaris Therapeutics filings at SEC.gov ↗